Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Oktober 2014 12:25 ET | Quelle: Real Endpoints

Move Over Gilead? AbbVie Could Bring Serious Competition to HCV Market

WESTPORT, CT--(Marketwired - Oct 13, 2014) - Gilead's Harvoni (sofosbuvir/ledipasvir combination) is the top overall scorer, according to RxScorecard, a drug-value assessment tool from Real...
15. Januar 2014 08:14 ET | Quelle: Reimbursement Intelligence

Reimbursement Intelligence Announces a Series of Major Key Strategic and Organization Changes

MADISON, NJ--(Marketwired - Jan 15, 2014) - Reimbursement Intelligence (RI), an information and marketing services firm that provides expert insights and solutions about the changing healthcare...
30. März 2012 11:32 ET | Quelle: Value & Innovation

Cancer Drug Costs Unsustainable, According to Value & Innovation Webinar

WESTPORT, CT--(Marketwire - Mar 30, 2012) - The current economic model for treating cancer is badly broken, according to senior executives from healthcare insurance companies who discussed the...
29. November 2011 10:07 ET | Quelle: Real Endpoints

Real Endpoints Launches New Reimbursement-Focused Information Service

WESTPORT, CT--(Marketwire - Nov 29, 2011) - Real Endpoints LLC, a new information company focused on healthcare reimbursement, announced today the launch of its Value & Innovation LLC...